Pyridobenzo- and pyridiothieno-diazepines useful for the treatme

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514220, 540542, 540557, A61K 3155, C07D47104, C07D49514

Patent

active

056021135

ABSTRACT:
Disclosed are novel pyrido[2,3,-b][1,5]benzodiazepines. These compounds are useful in the treatment of AIDS, ARC and related disorders associated with HIV infection. ##STR1##

REFERENCES:
patent: 3326900 (1967-06-01), Schmidt
patent: 3917585 (1975-11-01), Von Bebenburg
patent: 4560510 (1985-12-01), Lo
patent: 5087625 (1992-02-01), Hargrave et al.
J. Benditt and J. Cohen, Science, vol. 260, May 28, 1993, pp. 1253-1255.
Sandstrom et al., Review Article in Drugs, 34, pp. 373-390 (1987).
Yarchoan et al, AIDS: Modern Concepts and Therapeutic Challanges, Marcel Dekker Inc. pp. 335-360 (1987).
Hahn et al, "Nucleotide Dimers as Anti-Human Immuno-deficiency Virus Agents," in Nucleotide Analogues as Antiviral Agents, Martin ed, Amer. Chem. Soc., pp. 156-159 (1989).
March, Advanced Organiz Chem., 3rd ed. (1985), pp. 527-529.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyridobenzo- and pyridiothieno-diazepines useful for the treatme does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyridobenzo- and pyridiothieno-diazepines useful for the treatme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridobenzo- and pyridiothieno-diazepines useful for the treatme will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-342127

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.